NTRB Latest Press Releases

-- October 13, 2026 --

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274 Globe Newswire 8:00 AM

-- October 8, 2026 --

Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology Globe Newswire 7:00 AM

-- October 1, 2026 --

Nutriband Marks Five Years on Nasdaq - CEO Letter to Shareholders Globe Newswire 4:05 PM

-- September 29, 2026 --

Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis Globe Newswire 9:25 AM

-- September 25, 2026 --

Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board Globe Newswire 8:00 AM

-- September 22, 2026 --

Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing Globe Newswire 8:00 AM

-- September 9, 2026 --

Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit Globe Newswire 9:20 AM

-- September 8, 2026 --

Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch Globe Newswire 9:00 AM

-- August 13, 2026 --

Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes